Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun Tang

Showing results (871-880 of 894) with videos related to

Pageof 90
Sort By:
European Journal of Medicinal Chemistry|July 11, 2017
Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapyWenhua Chen, Ne Guo, Minghui Qi, et al.
Biological Reviews of the Cambridge Philosophical Society|July 21, 2021
A comprehensive synthesis unveils the mysteries of phosphate-solubilizing microbesJin-Tian Li, Jing-Li Lu, Hong-Yu Wang, et al.
The Oncologist|February 8, 2024
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal CancersNatalie Y L Ngoi, Tin-Yun Tang, Catia F Gaspar, et al.
JACC. Cardiovascular Imaging|February 18, 2026
Serial Myocardial Fibrosis Assessments Predict Outcomes in Patients With Hypertrophic CardiomyopathyYun Tang, Xingrui Chen, Kankan Zhao, et al.
Journal of Hematology & Oncology|April 8, 2024
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trialXinxin Wang, Canrong Lu, Bo Wei, et al.
ACS Central Science|May 11, 2016
Mesoporous TiO2 Mesocrystals: Remarkable Defects-Induced Crystallite-Interface Reactivity and Their in Situ Conversion to Single CrystalsYong Liu, Yongfeng Luo, Ahmed A Elzatahry, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in MelanomaRui-Yan Wu, Peng-Fei Kong, Liang-Ping Xia, et al.
Nucleic Acids Research|November 11, 2024
dbPTM 2025 update: comprehensive integration of PTMs and proteomic data for advanced insights into cancer researchChia-Ru Chung, Yun Tang, Yen-Peng Chiu, et al.
Cell Discovery|December 14, 2020
A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1Zhenghui Huang, Ruoxi Li, Tongke Tang, et al.
Pageof 90

Showing results (871-880 of 894) with videos related to

Sort By:
Pageof 90
European Journal of Medicinal Chemistry|July 11, 2017
Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapyWenhua Chen, Ne Guo, Minghui Qi, et al.
Biological Reviews of the Cambridge Philosophical Society|July 21, 2021
A comprehensive synthesis unveils the mysteries of phosphate-solubilizing microbesJin-Tian Li, Jing-Li Lu, Hong-Yu Wang, et al.
The Oncologist|February 8, 2024
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal CancersNatalie Y L Ngoi, Tin-Yun Tang, Catia F Gaspar, et al.
JACC. Cardiovascular Imaging|February 18, 2026
Serial Myocardial Fibrosis Assessments Predict Outcomes in Patients With Hypertrophic CardiomyopathyYun Tang, Xingrui Chen, Kankan Zhao, et al.
Journal of Hematology & Oncology|April 8, 2024
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trialXinxin Wang, Canrong Lu, Bo Wei, et al.
ACS Central Science|May 11, 2016
Mesoporous TiO2 Mesocrystals: Remarkable Defects-Induced Crystallite-Interface Reactivity and Their in Situ Conversion to Single CrystalsYong Liu, Yongfeng Luo, Ahmed A Elzatahry, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in MelanomaRui-Yan Wu, Peng-Fei Kong, Liang-Ping Xia, et al.
Nucleic Acids Research|November 11, 2024
dbPTM 2025 update: comprehensive integration of PTMs and proteomic data for advanced insights into cancer researchChia-Ru Chung, Yun Tang, Yen-Peng Chiu, et al.
Cell Discovery|December 14, 2020
A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1Zhenghui Huang, Ruoxi Li, Tongke Tang, et al.
Pageof 90